Loading...

Choose your country and language

You are currently on

Australia

Australia

Setting the global standard in infection prevention

Nanosonics has the largest presence in automated HLD technology across the world

Setting the global standard in infection prevention

Nanosonics has the largest presence in automated HLD technology across the world

Wherever you are, trophon is there

The trophon platform is endorsed by more manufacturers and clinicians globally than high-level disinfection (HLD) alternatives

>35,000 trophon devices operating

across thousands of hospitals

in 35+ countries

protect 27 million patients each year1

trophon technology has become standard of care for ultrasound probe reprocessing in Australia, the USA, and the UK, with trophon devices listed as approved HLD devices across various health services and frameworks, including:


NHS Shared Business Services Framework


RESAH


NSW Health


USA Government facilities

Committed to customer success – now and in the future

With a global network of offices in major markets including the USA, Canada, UK, France, Germany, Ireland, Japan, and Australia, along with an expanding distributor base across the world, Nanosonics has an established global supply chain to continue to provide unparalleled service and supply of trophon technology.

Nanosonics operates in 36 countries and counting
– explore the map to find out where.

Use existing interactive image from website page https://www.nanosonics.com/global-presence, but suggest colour coding or labelling regions on the map

Nanosonics operates in the following countries

Abbreviations: HLD, high-level disinfection; NHS, National Health Service; NSW, New South Wales; USA, United States of America.

Reference: 1. Nanosonics Annual Report 2024 .

THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC
THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC